Endra Life Sciences Inc.
NDRA
Revenue
0.00
0.000.00%
3 Months ChangeAssets
10.44M
▲5.38M▲106.35%
3 Months ChangeLiabilities
1.45M
▲86.06k▲6.32%
3 Months ChangeFree Cash Flow
-2.17M
▲362.54k▲14.31%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001654954-24-013446
2024-08-28
Form 8-K
ID: 0001654954-24-011213
2024-08-23
Form 8-K
ID: 0001654954-24-011072
2024-08-16
Form 8-K
ID: 0001654954-24-010837
2024-08-14
Form 10-Q
ID: 0001654954-24-010642
2024-08-13
Form 8-K
ID: 0001654954-24-010399
2024-08-09
Form 8-K
ID: 0001654954-24-010213
2024-07-17
Form 8-K
ID: 0001654954-24-009066
2024-06-06
Form 8-K
ID: 0001654954-24-007415
2024-05-20
Form 8-K
ID: 0001654954-24-006635